Safety and efficacy of a novel transbronchial radiofrequency ablation system for lung tumours: One year follow‐up from the first multi‐centre large‐scale clinical trial (BRONC‐RFII) - Zhong, Changhao; Chen, Enguo; Su, Zhuquan; Chen, Difei; Wang, Feng; Wang, Xiaoping; Liu, Guangnan; Zhang, Xiaoju; Luo, Fengming; Zhang, Nan; Wang, Hongwu; Jin, Longyu; et al. (Respirology (Carlton, Vic.), 2025)
Keywords: Ablation; Adult; Aged; Aged, 80 and over; bronchoscopy; Bronchoscopy - instrumentation; Bronchoscopy - methods; Catheter Ablation - adverse effects; Catheter Ablation - instrumentation; Catheter Ablation - methods; Clinical trials; Female; Follow-Up Studies; ground‐glass nodule; Humans; Lung cancer; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Lung Neoplasms - surgery; lung tumour; Male; Middle Aged; Nodules; Original; ORIGINAL ARTICLE; Patients; Pleural effusion; Pneumothorax; Radiofrequency ablation; Radiofrequency Ablation - adverse effects; Radiofrequency Ablation - instrumentation; Radiofrequency Ablation - methods; Survival; Survival Rate; Treatment Outcome; Tumors; Young Adult; lung tumour; radiofrequency ablation; ground‐glass nodule; bronchoscopy